These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 38917953)
1. Biomimetic gold nanocages incorporating copper-human serum albumin for tumor immunotherapy via cuproptosis-lactate regulation. Zafar H; Zhang J; Raza F; Pan X; Hu Z; Feng H; Shen Q J Control Release; 2024 Aug; 372():446-466. PubMed ID: 38917953 [TBL] [Abstract][Full Text] [Related]
2. Sono-Triggered Cascade Lactate Depletion by Semiconducting Polymer Nanoreactors for Cuproptosis-Immunotherapy of Pancreatic Cancer. Yu N; Zhou J; Ding M; Li M; Peng S; Li J Angew Chem Int Ed Engl; 2024 Jul; 63(30):e202405639. PubMed ID: 38708791 [TBL] [Abstract][Full Text] [Related]
3. Biomimetic copper-doped polypyrrole nanoparticles induce glutamine metabolism inhibition to enhance breast cancer cuproptosis and immunotherapy. Zhang N; Ping W; Rao K; Zhang Z; Huang R; Zhu D; Li G; Ning S J Control Release; 2024 Jul; 371():204-215. PubMed ID: 38810704 [TBL] [Abstract][Full Text] [Related]
4. Copper-coordinated nanoassemblies based on photosensitizer-chemo prodrugs and checkpoint inhibitors for enhanced apoptosis-cuproptosis and immunotherapy. Liang W; Han C; Zhang D; Liu C; Zhu M; Xu F; Fang C; Zhang S; Liu C; Li Y Acta Biomater; 2024 Feb; 175():341-352. PubMed ID: 38122883 [TBL] [Abstract][Full Text] [Related]
5. A biomimetic cuproptosis amplifier for targeted NIR-II fluorescence/photoacoustic imaging-guided synergistic NIR-II photothermal immunotherapy. Dai Y; Zhu L; Li X; Zhang F; Chen K; Jiao G; Liu Y; Yang Z; Guo Z; Zhang B; Shen Q; Zhao Q Biomaterials; 2024 Mar; 305():122455. PubMed ID: 38160626 [TBL] [Abstract][Full Text] [Related]
6. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
7. A dual-pathway pyroptosis inducer based on Au-Cu Yan X; Chen C; Ren Y; Su T; Chen H; Yu D; Huang Y; Chao M; Wu G; Jiang G; Gao F Acta Biomater; 2024 Oct; 188():329-343. PubMed ID: 39278301 [TBL] [Abstract][Full Text] [Related]
8. Glutathione-Scavenging Celastrol-Cu Nanoparticles Induce Self-Amplified Cuproptosis for Augmented Cancer Immunotherapy. Lu S; Li Y; Yu Y Adv Mater; 2024 Aug; 36(35):e2404971. PubMed ID: 38935977 [TBL] [Abstract][Full Text] [Related]
9. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases. Liang R; Liu L; He H; Chen Z; Han Z; Luo Z; Wu Z; Zheng M; Ma Y; Cai L Biomaterials; 2018 Sep; 177():149-160. PubMed ID: 29890364 [TBL] [Abstract][Full Text] [Related]
10. Copper Deposition in Polydopamine Nanostructure to Promote Cuproptosis by Catalytically Inhibiting Copper Exporters of Tumor Cells for Cancer Immunotherapy. Chang J; Yin W; Zhi H; Chen S; Sun J; Zhao Y; Huang L; Xue L; Zhang X; Zhang T; Dong H; Li Y Small; 2024 Jul; 20(27):e2308565. PubMed ID: 38339770 [TBL] [Abstract][Full Text] [Related]
11. Elesclomol Loaded Copper Oxide Nanoplatform Triggers Cuproptosis to Enhance Antitumor Immunotherapy. Lu X; Chen X; Lin C; Yi Y; Zhao S; Zhu B; Deng W; Wang X; Xie Z; Rao S; Ni Z; You T; Li L; Huang Y; Xue X; Yu Y; Sun W; Shen X Adv Sci (Weinh); 2024 May; 11(18):e2309984. PubMed ID: 38430531 [TBL] [Abstract][Full Text] [Related]
12. Human Serum Albumin Mediated Controllable Synthesis of Defect-Rich Copper Hydroxide Nanowire for Cuproptosis-Based Anti-Tumor Therapy. Man R; Xia M; Li H; Tian F; Zhang J; Yu Z; Tang B Adv Healthc Mater; 2024 Sep; 13(23):e2401078. PubMed ID: 38708719 [TBL] [Abstract][Full Text] [Related]
13. Single-Site Nanozymes with a Highly Conjugated Coordination Structure for Antitumor Immunotherapy via Cuproptosis and Cascade-Enhanced T Lymphocyte Activity. Liu Y; Niu R; Zhao H; Wang Y; Song S; Zhang H; Zhao Y J Am Chem Soc; 2024 Feb; 146(6):3675-3688. PubMed ID: 38305736 [TBL] [Abstract][Full Text] [Related]
14. Inhalable metal-organic framework-mediated cuproptosis combined with PD-L1 checkpoint blockade for lung metastasis synergistic immunotherapy. Yan C; Liu Y; Zhao G; Yang H; Lv H; Li G; Li Y; Fu Y; Sun F; Feng Y; Li Y; Zhao Z Acta Pharm Sin B; 2024 May; 14(5):2281-2297. PubMed ID: 38799628 [TBL] [Abstract][Full Text] [Related]
15. Copper(II)-Based Nano-Regulator Correlates Cuproptosis Burst and Sequential Immunogenic Cell Death for Synergistic Cancer Immunotherapy. Luo Y; Luo X; Ru Y; Zhou X; Liu D; Huang Q; Linghu M; Wu Y; Lv Z; Chen M; Ma Y; Huang Y; Wang J Biomater Res; 2024; 28():0039. PubMed ID: 38938647 [TBL] [Abstract][Full Text] [Related]
16. A Self-Amplifying ROS-Responsive Nanoplatform for Simultaneous Cuproptosis and Cancer Immunotherapy. Wu H; Zhang Z; Cao Y; Hu Y; Li Y; Zhang L; Cao X; Wen H; Zhang Y; Lv H; Jin X Adv Sci (Weinh); 2024 Jun; 11(23):e2401047. PubMed ID: 38569217 [TBL] [Abstract][Full Text] [Related]
17. Sequentially responsive biomimetic nanoparticles with optimal size in combination with checkpoint blockade for cascade synergetic treatment of breast cancer and lung metastasis. Yu W; He X; Yang Z; Yang X; Xiao W; Liu R; Xie R; Qin L; Gao H Biomaterials; 2019 Oct; 217():119309. PubMed ID: 31271855 [TBL] [Abstract][Full Text] [Related]
18. Photoinduced Cuproptosis with Tumor-Specific for Metastasis-Inhibited Cancer Therapy. Zheng J; Ge H; Guo M; Zhang T; Hu Q; Yao Q; Long S; Sun W; Fan J; Du J; Peng X Small; 2024 Mar; 20(10):e2304407. PubMed ID: 37880907 [TBL] [Abstract][Full Text] [Related]
19. Artificial Enzyme Catalyzed Cascade Reactions: Antitumor Immunotherapy Reinforced by NIR-II Light. Wen M; Ouyang J; Wei C; Li H; Chen W; Liu YN Angew Chem Int Ed Engl; 2019 Nov; 58(48):17425-17432. PubMed ID: 31552695 [TBL] [Abstract][Full Text] [Related]
20. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy. Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]